On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Funds Cannabis Companies with Innovative Royalty Financing Model

  • FinCanna advances $2.25 million to Refined Resin Technologies and ezGreen Compliance
  • California sales account for one-third of U.S. cannabis market
  • California market projected to grow by CAGR of 23 percent to $6.5 billion by 2020

California is now home to the largest legal cannabis market in the world. A pioneer of medical marijuana, which it legalized in 1998, the state has gone a step further by legalizing adult use of marijuana as of January 1, 2018. As a result, sales, already accounting for one-third of legal cannabis sales revenues in the U.S., are projected to reach $4.3 billion in 2018 and continue to grow to $6.5 billion by 2020, according to Arcview Research & New Frontier Data. But such rapid growth won’t be possible unless the industry can attract funding, which means that the services provided by specialty financing company FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) will likely be in high demand. FinCanna Capital, a royalty company for the licensed U.S. medical cannabis industry, provides capital to licensed medical cannabis companies in exchange for a percentage of future cash flows under a royalty financing model.

FinCanna Capital might have taken a leaf from the mining industry playbook, since royalty companies, sometimes referred to as streaming companies, are active in the precious metals industry. They fund the exploration and production activities of miners and, in return, receive rights over a percentage of future revenue streams. FinCanna’s modus operandi will be similar. The company will provide upfront advances to cannabis companies in return for a future stream of royalty payments.

Royalty financing offers several benefits to startup cannabis companies. Compared to equity financing from private or public investors, it can be a more palatable solution for shareholders, since it requires no transfer or dilution of equity. Accordingly, owners are also at less risk of losing control of their businesses. In royalty financing, investors own a piece of the company’s revenue stream rather than a piece of the company itself.

Royalty financing may also be less burdensome than debt. With a loan or bond, interest payments are usually fixed and can be difficult to change if business conditions deteriorate. However, flexibility is built into the royalty financing structure, since royalty payments are linked to revenues or cash flows.

FinCanna is already making its presence felt. The company recently announced that it had advanced $1.25 million, an initial tranche of capital, to Refined Resin Technologies (http://nnw.fm/so1XZ). Refined Resin is retrofitting a legally zoned, large, state-of-the-art medical cannabis extraction laboratory in Oakland, California, that’s expected to be in operation by late 2018 or early 2019. Refined Resin has extensive experience in extraction, manufacturing and business operations and intends to be premier producers of bulk quantities of THC (tetrahydrocannabinol) distillate and various high-value concentrates produced via hydrocarbon-based solvent extraction.

Around the same time, FinCanna also revealed that it had advanced $1 million to ezGreen Compliance, which offers a state-of-the-art enterprise compliance and point-of-sale software solution for licensed medical cannabis dispensaries and cultivators (http://nnw.fm/S1Fax).

FinCanna also announced the appointment of John Campbell to its advisory board. Campbell has over 35 years of experience in the investment industry, and currently serves as chairman and CFO of TriView Capital, one of Canada’s largest Exempt Market Dealers (http://nnw.fm/QXHl4).

FinCanna’s first investment in California, Cultivation Technologies, recently executed an agreement with Phoenix Tears LLC, to be the exclusive manufacturer and distributer of official Phoenix Tears THC-based products in California. The Phoenix Tears-branded portfolio of THC based products will initially include a full spectrum of oil dispensers, vaporizer cartridges and vaporizer kits, as well as topicals (http://nnw.fm/mF7az).

For more information, visit the company’s website at www.FinCannaCapital.com

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEDAR filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Archives

Select A Month

Contact us: 212.418.1217